Magnetic Resonance Angiography

LCD Information Document Information Source LCD ID N/A LCD ID L34424 Original ICD-9 LCD ID Not Applicable LCD Title Magnetic Resonance Angiography Proposed LCD in Comment Period N/A Source Proposed LCD DL34424 Opens in a new window Original Effective Date For services performed on or after 10/01/2015 Revision Effective Date For services performed on or after 03/27/2025 Revision Ending Date N/A Retirement Date N/A Notice Period Start Date 12/12/2024 Notice Period End Date 03/26/2025 CPT codes, descriptions, and other data only are copyright 2025 American Medical Association. All Rights Reserved. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein. CPT is a registered trademark of the American Medical Association. Current Dental Terminology © 2025 American Dental Association. All rights reserved. Copyright © 2026, the American Hospital Association, Chicago, Illinois. Reproduced with permission. No portion of the AHA copyrighted materials contained within this publication may be copied without the express written consent of the AHA. AHA copyrighted materials including the UB‐04 codes and descriptions may not be removed, copied, or utilized within any software, product, service, solution, or derivative work without the written consent of the AHA. If an entity wishes to utilize any AHA materials, please contact the AHA at ub04@aha.org or 312‐422‐3366. Making copies or utilizing the content of the UB‐04 Manual, including the codes and/or descriptions, for internal purposes, resale and/or to be used in any product or publication; creating any modified or derivative work of the UB‐04 Manual and/or codes and descriptions; and/or making any commercial use of UB‐04 Manual or any portion thereof, including the codes and/or descriptions, is only authorized with an express license from the American Hospital Association. The American Hospital Association (the "AHA") has not reviewed, and is not responsible for, the completeness or accuracy of any information contained in this material, nor was the AHA or any of its affiliates, involved in the preparation of this material, or the analysis of information provided in the material. The views and/or positions presented in the material do not necessarily represent the views of the AHA. CMS and its products and services are not endorsed by the AHA or any of its affiliates. Issue Issue Description This LCD outlines limited coverage for this service with specific details under Coverage Indications, Limitations and/or Medical Necessity. Issue - Explanation of Change Between Proposed LCD and Final LCD No changes between Proposed LCD and Final LCD. CMS National Coverage Policy Title XVIII of the Social Security Act, §1862(a)(1)(A) allows coverage and payment for only those services that are considered to be medically reasonable and necessary for the diagnosis or treatment of illness or injury or to improve the functioning of a malformed body member.Title XVIII of the Social Security Act, §1862(a)(1)(E) excludes expenses for items or services which are not reasonable and necessary to carry out research conducted pursuant to §1142 of the Act. Title XVIII of the Social Security Act, §1862(a)(7) states Medicare will not cover any services or procedures associated with routine physical checkups. 42 CFR §410.32 indicates that diagnostic tests may only be ordered by the treating physician (or other treating practitioner acting within the scope of his or her license and Medicare requirements). CMS Internet-Only Manual, Pub. 100-02, Medicare Benefit Policy Manual, Chapter 15, §80 Requirements for Diagnostic X-Ray, Diagnostic Laboratory, and Other Diagnostic TestsCMS Internet-Only Manual, Pub. 100-02, Medicare Benefit Policy Manual, Chapter 16, §20 Services Not Reasonable and NecessaryCMS Internet-Only Manual, Pub. 100-03, Medicare National Coverage Determinations (NCD) Manual, Chapter 1, Part 4, §220.2 Magnetic Resonance Imaging (MRI). Coverage Indications, Limitations, and/or Medical Necessity Magnetic resonance angiography (MRA) is a modern diagnostic technique based on the effect of nuclear magnetic resonance and is like magnetic resonance imaging (MRI). During the procedure, the device reads electromagnetic waves received during the oscillation of the nuclei of hydrogen atoms, after which the computer converts the information received into a three-dimensional image of the zone under study. MRA is utilized to carry out studies of arteries, veins and lymphatic vessels of any location, to carry out a detailed assessment of the state of vascular networks, to identify pathological changes in the early stages, and to determine the cause of the pathology.1 The coverage criteria and definition of MRA are found in the CMS Internet-only Manual, Pub. 100-03, Medicare National Coverage Determinations (NCD) Manual, Chapter 1, Part 4, §220.2. MRA with or without contrast is considered appropriate when it can replace a more invasive test (e.g., contrast angiography) and reduce risk for beneficiaries. MRA is a covered indication for various diseases and abnormalities involving the arterial, venous and lymphatic systems. In addition, the services must be reasonable and necessary for the diagnosis or treatment of the specific patient involved. The use of MRA would have the same contraindications as MRI and should not be used in patients with implanted ferromagnetic structures and electronic devices. Summary of Evidence MRA encompasses several imaging techniques based on MRI developed for studying the arterial and venous systems. The benefits of an MRA in comparison to traditional angiography is that it is noninvasive, it lacks ionizing radiation exposure, it has the potential for a non-contrast examination, and it can produce high-resolution volumetric images. The MRA gadolinium contrast material is less likely to cause an allergic reaction than the iodine-based contrast materials used for computed tomography scanning. An MRA is often indicated to evaluate the following abnormalities and conditions and is used for screening1 and monitoring purposes1: arterial aneurysm(s)1, arteriovenous malformations2-4, aortic coarctation1, aortic dissection5,6, cerebral stroke1, carotid artery disease7,8, peripheral atherosclerosis of the extremities1, congenital heart disease1, coronary artery disease and, if indicated, graft patency9-12, mesentery artery ischemia13,14, renal artery stenosis15, pulmonary embolism16,17, trigeminal neuralgia18-20, moyamoya disease21,22 and intracranial aneurysms.23,24 MRA has the same contraindications as MRI, including patients with implanted ferromagnetic structures and electronic devices. Such devices might include, but are not limited to the following: a cardiac implantable electronic device, mechanical metallic heart valves, metallic foreign bodies, implantable neurostimulation system, cochlear implants/ear implant, non-removable drug infusion pumps, catheters with metallic components, cerebral artery aneurysm clips which are non-MRI compatible, and tissue expanders with magnetic infusion ports.25 Other contraindications for use of the contrast medium include a previous allergic or anaphylactic reaction to gadolinium.26 Analysis of Evidence (Rationale for Determination) MRA of cerebral vessels is useful to create detailed three-dimensional images of vascular networks and surrounding brain tissues, identify hematomas, hemorrhages, aneurysms, arteriovenous shunts and areas of circulatory disorders. MRI angiography is indicated for suspected post-traumatic intracranial hematoma, stroke, chronic cerebral ischemia with vertebrobasilar insufficiency, encephalopathy, post-traumatic or post-stroke changes, as well as with vegetative-vascular dystonia, pituitary adenoma, Parkinson’s disease and some other pathological conditions. The study can be both with and without contrast. MRA of the vessels of the extremities is utilized to determine the structure of vascular networks, the condition, localization and interposition of the arteries and veins of the extremities, as well as hemodynamic parameters in unchanged areas and areas of pathological changes. MRA is used for atherosclerosis, vasculitis, thrombosis, chronic venous insufficiency, angiopathies of various genesis, traumatic injuries of arteries and veins, compression or germination of vessels by neoplasms, aneurysms, malformations and vascular dysplasia of the extremities. In some cases, contrast-free MRA is performed. When indicated, gadolinium contrast is used. MRA of mesenteric vessels is performed to recreate a complete picture of the localization and structure of the abdominal aorta and the vessels departing from it and to identify various pathological changes (structural abnormalities, stenosis, occlusion, traumatic injury, etc.). MRA is prescribed for circulatory disorders in the abdominal aorta basin, with suspicion of abdominal aorta coarctation, atherosclerotic lesion of abdominal vessels, aneurysm aorta, malformations and vascular ruptures of traumatic origin. Vascular contrast can be used to increase the informative value of MRA. MRA of the lymphatic system makes it possible to assess the condition of the entire lymphatic system and its individual areas. During the procedure, lymph nodes and large collectors are examined. A determination of the level of fluid content in tissues can be made and conclusions about the degree of disruption of lymphatic drainage function can be ascertained. MRA is used for lymphedema caused by inflammatory processes, oncological lesions and fibrous changes that have arisen as a result of previously treated and untreated diseases.27 In addition, when utilized to make a diagnosis, MRA of the spinal vessels, MRA of the heart and coronary vessels, MRA of the thoracic aorta and several other studies may also be indicated. Based upon the evidence reviewed, there may be other indications for MRA due to its utility to detect abnormalities involving the blood vessels and lymphatic system. Therefore, MRA is considered reasonable and necessary with and without contrast agent to assess any of the above indications and can be used for other vascular abnormalities when clinical indications are reasonable and necessary.

Magnetic resonance angiography (MRA) is a modern diagnostic technique based on the effect of nuclear magnetic resonance and is like magnetic resonance imaging (MRI). During the procedure, the device reads electromagnetic waves received during the oscillation of the nuclei of hydrogen atoms, after which the computer converts the information received into a three-dimensional image of the zone under study. MRA is utilized to carry out studies of arteries, veins and lymphatic vessels of any location, to carry out a detailed assessment of the state of vascular networks, to identify pathological changes in the early stages, and to determine the cause of the pathology. 1 The coverage criteria and definition of MRA are found in the CMS Internet-only Manual, Pub. 100-03, Medicare National Coverage Determinations (NCD) Manual, Chapter 1, Part 4, §220.2. MRA with or without contrast is considered appropriate when it can replace a more invasive test (e.g., contrast angiography) and reduce risk for beneficiaries. MRA is a covered indication for various diseases and abnormalities involving the arterial, venous and lymphatic systems. In addition, the services must be reasonable and necessary for the diagnosis or treatment of the specific patient involved. The use of MRA would have the same contraindications as MRI and should not be used in patients with implanted ferromagnetic structures and electronic devices.